Fea4 Gene Expression Control for Maize Meristem Size

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods lack effective control over shoot and floral meristem development in plants, leading to inconsistent yields and appearances in crops such as maize, which affects the production of leaves, flowers, and fruit.

Innovation Solution

A method involving the production of transgenic plants with decreased expression of the Fea4 gene using recombinant DNA constructs, specifically introducing polynucleotides linked to promoters that reduce Fea4 expression, thereby altering agronomic characteristics like ear meristem size, kernel row number, and yield.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If current methods are used for plant development control, then general plant growth occurs, but precise control over meristem development and yield is lacking

Engineering Contradiction:
ImproveyieldVSAvoidcontrol mechanism
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent uses RNA interference (RNAi) as an intermediary mechanism to control Fea4 gene expression. The RNAi construct acts as a mediator between the promoter and the Fea4 gene, enabling precise control over meristem development and yield without directly manipulating the Fea4 gene itself. This resolves the contradiction by providing a sophisticated control mechanism that achieves high productivity through an intermediate molecular pathway.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes the expression level parameter of the Fea4 gene to control plant development. By reducing Fea4 expression through RNA interference, the patent achieves precise control over meristem size, ear development, and yield. This parameter change approach resolves the contradiction by transforming the qualitative control problem into a quantitative expression level adjustment.

Inventive Principle:
Principle #35Parameter changes

2Manufacturing precision

If Fea4 expression is reduced to control meristem size, then ear meristem size and kernel row number improve, but requires specific transgenic approaches

Engineering Contradiction:
Improveear meristem size controlVSAvoidtransgenic plant production
Core Design Contradiction:
Manufacturing precisionVSEase of manufacture

Solution Approach 1:

The RNA interference construct serves as an intermediary that enables precise control of Fea4 expression without requiring direct manipulation of the Fea4 gene structure. This mediator approach achieves manufacturing precision in ear meristem size control while using a standardized transgenic methodology, thereby improving ease of manufacture compared to gene editing approaches.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent uses a copied and modified version of the Fea4 gene sequence within the RNA interference construct. Instead of directly editing the native Fea4 gene, the invention creates a complementary RNA copy that interferes with Fea4 expression. This copying strategy achieves precise control over ear meristem size while maintaining the original gene intact, simplifying the transgenic production process.

Inventive Principle:
Principle #26Copying

3Adaptability or versatility

If CLV/WUS pathway is manipulated to control stem cell division, then meristem size can be regulated, but specific pathway component control is limited

Engineering Contradiction:
Improvemeristem size regulationVSAvoidsignal pathway manipulation
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent extracts the control function from the complex CLV/WUS signaling pathway and focuses specifically on the Fea4 gene component. By targeting Fea4 expression reduction through RNA interference, the invention isolates a specific control point within the broader pathway, achieving meristem size regulation without requiring manipulation of multiple pathway components. This extraction approach increases adaptability while reducing device complexity.

Inventive Principle:
Principle #2Taking out (Extraction)

Data Source

PatentUS9850495B2Nucleotide sequences encoding fasciated EAR4 (FEA4) and methods of use thereof
Publication Date: 2017.12.26 CORTEVA AGRISCIENCE LLC
  • US9850495B2 patent drawing
  • US9850495B2 patent drawing
  • US9850495B2 patent drawing

AI summary

Methods and compositions for modulating shoot apical meristem size are provided. Methods are provided for modulating the expression of Fea4 sequence in a host plant or plant cell to modulate agronomic characteristics such as altered size and number of organs, including plant seeds.